*
*
*
(on a scale of 1 – 4, with 1 being the not confident and 4 being the very confident)
1234
Conventional synthetic DMARDs (e.g. methotrexate)
Tumor necrosis factor targeted monoclonal antibodies (mAB) (e.g. infliximab)
CD-20 directed monoclonal antibodies (e.g. rituximab)
CTLA-4 targeted therapy (e.g. abatacept)
Il-6 targeted monoclonal antibodies (e.g.tocilizumab)
JAK inhibitors (e.g. tofacitinib)
*
*
*
*
*

If you are interested in participating in the raffle for a $100 Amazon gift card, please fill out the following: